Stelac Advisory Services LLC Invitae Corp Transaction History

Stelac Advisory Services LLC

  • $239 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$24.31 - $33.6 $83,334 - $115,180
-3,428 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$26.09 - $40.4 $7,566 - $11,716
-290 Reduced 7.8%
3,428 $116,000
Q4 2020

Feb 11, 2021
BUY
$39.09 - $57.4 $145,336 - $213,413
3,718 New
3,718 $155,000

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Stelac Advisory Services LLC Portfolio

Follow Stelac Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stelac Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stelac Advisory Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email